Bjoern D Suckow1, Philip P Goodney2, Brian W Nolan2, Ravi K Veeraswamy3, Patricia Gallagher4, Jack L Cronenwett2, Larry W Kraiss5. 1. Division of Vascular Surgery, University of Utah School of Medicine, Salt Lake City, UT. Electronic address: bjoern.suckow@hsc.utah.edu. 2. Section of Vascular Surgery, Dartmouth Medical School, Hanover, NH. 3. Division of Vascular Surgery, Emory University School of Medicine, Atlanta, GA. 4. Center for Survey Research, University of Massachusetts, Boston, MA. 5. Division of Vascular Surgery, University of Utah School of Medicine, Salt Lake City, UT.
Abstract
BACKGROUND: Although patients with critical limb ischemia (CLI) commonly undergo major limb amputation, the quality of life (QOL) of this group remains poorly described. Therefore, we sought to describe which domains vascular amputees consider important in determining their health-related QOL. METHODS: We performed 4 focus groups in patients who had major lower extremity amputations resulting from CLI. They were conducted at 4 distinct centers across the United States to ensure broad geographic, socioeconomic, and ethnic representation. RESULTS: Of 26 patients (mean age, 64 years), 19 (73%) were Caucasian, 6 (23%) were African American, and 1 (4%) was Native American. Nearly, three-quarter of patients were men (n = 19, 73%) and had a high-school education or more (n = 19, 73%). Overall, 8 (31%) were double amputees and 17 (65%) had diabetes. Time since amputation varied across patients and ranged from 3 months to more than 27 years (mean, 4.3 years). Patients stated that their current QOL was determined by impaired mobility (65%), pain (60%), progression of disease in the remaining limb (55%), and depression/frustration (54%). Across 26 patients, more than half (n = 16, 62%) described multiple prior revascularization procedures. Although most felt that their physician did his/her best to salvage the affected leg (85%), a sizable minority would have preferred an amputation earlier in their CLI treatment course (27%). Furthermore, when asked how their care might have been improved, patients reported that facilitating peer support (88%), more extensive rehabilitation and prosthetist involvement (71%), earlier mention of amputation as a possible outcome (54%), and the early discontinuation of narcotics (54%) were potential areas of improvement. CONCLUSIONS: Although QOL in vascular amputees seems primarily determined by mobility impairment, pain, and emotional perturbation, our focus groups identified that physician-controlled factors such as the timing of amputation, informed decision making, and postamputation support may also play an important role. The assessment of patient preferences regarding maintenance of mobility at the cost of increased pain versus relief of pain with amputation at a cost of diminished mobility is central to shared decision making in CLI treatment.
BACKGROUND: Although patients with critical limb ischemia (CLI) commonly undergo major limb amputation, the quality of life (QOL) of this group remains poorly described. Therefore, we sought to describe which domains vascular amputees consider important in determining their health-related QOL. METHODS: We performed 4 focus groups in patients who had major lower extremity amputations resulting from CLI. They were conducted at 4 distinct centers across the United States to ensure broad geographic, socioeconomic, and ethnic representation. RESULTS: Of 26 patients (mean age, 64 years), 19 (73%) were Caucasian, 6 (23%) were African American, and 1 (4%) was Native American. Nearly, three-quarter of patients were men (n = 19, 73%) and had a high-school education or more (n = 19, 73%). Overall, 8 (31%) were double amputees and 17 (65%) had diabetes. Time since amputation varied across patients and ranged from 3 months to more than 27 years (mean, 4.3 years). Patients stated that their current QOL was determined by impaired mobility (65%), pain (60%), progression of disease in the remaining limb (55%), and depression/frustration (54%). Across 26 patients, more than half (n = 16, 62%) described multiple prior revascularization procedures. Although most felt that their physician did his/her best to salvage the affected leg (85%), a sizable minority would have preferred an amputation earlier in their CLI treatment course (27%). Furthermore, when asked how their care might have been improved, patients reported that facilitating peer support (88%), more extensive rehabilitation and prosthetist involvement (71%), earlier mention of amputation as a possible outcome (54%), and the early discontinuation of narcotics (54%) were potential areas of improvement. CONCLUSIONS: Although QOL in vascular amputees seems primarily determined by mobility impairment, pain, and emotional perturbation, our focus groups identified that physician-controlled factors such as the timing of amputation, informed decision making, and postamputation support may also play an important role. The assessment of patient preferences regarding maintenance of mobility at the cost of increased pain versus relief of pain with amputation at a cost of diminished mobility is central to shared decision making in CLI treatment.
Authors: Philip P Goodney; Andres Schanzer; Randall R Demartino; Brian W Nolan; Nathanael D Hevelone; Michael S Conte; Richard J Powell; Jack L Cronenwett Journal: J Vasc Surg Date: 2011-02-18 Impact factor: 4.268
Authors: Louis L Nguyen; Gregory L Moneta; Michael S Conte; Dennis F Bandyk; Alexander W Clowes; B Lynn Seely Journal: J Vasc Surg Date: 2006-11 Impact factor: 4.268
Authors: Andres Schanzer; Jessica Mega; Judith Meadows; Russell H Samson; Dennis F Bandyk; Michael S Conte Journal: J Vasc Surg Date: 2008-12 Impact factor: 4.268
Authors: James M Peacock; Hong H Keo; Sue Duval; Iris Baumgartner; Niki C Oldenburg; Michael R Jaff; Timothy D Henry; Xinhua Yu; Alan T Hirsch Journal: Prev Chronic Dis Date: 2011-10-17 Impact factor: 2.830
Authors: Brian J Hafner; Ignacio A Gaunaurd; Sara J Morgan; Dagmar Amtmann; Rana Salem; Robert S Gailey Journal: Arch Phys Med Rehabil Date: 2016-08-30 Impact factor: 3.966
Authors: D C Norvell; M L Thompson; E J Boyko; G Landry; A J Littman; W G Henderson; A P Turner; C Maynard; K P Moore; J M Czerniecki Journal: Br J Surg Date: 2019-03-13 Impact factor: 6.939
Authors: Keren Lehavot; Jessica P Young; Rachel M Thomas; Rhonda M Williams; Aaron P Turner; Daniel C Norvell; Joseph M Czerniecki; Anna Korpak; Alyson J Littman Journal: J Gen Intern Med Date: 2022-09-01 Impact factor: 6.473
Authors: Ahmed Aber; Elizabeth Lumley; Patrick Phillips; Helen Buckley Woods; Georgina Jones; Jonathan Michaels Journal: Patient Date: 2018-10 Impact factor: 3.883
Authors: Muhammad Adeel Akhtar; Jason Shih Hoellwarth; Shakib Al-Jawazneh; William Lu; Claudia Roberts; Munjed Al Muderis Journal: JB JS Open Access Date: 2021-06-23